Fonar - 27 Year Stock Price History | FONR

Historical daily share price chart and data for Fonar since 1993 adjusted for splits. The latest closing stock price for Fonar as of September 25, 2020 is 21.81.
  • The all-time high Fonar stock closing price was 112.50 on March 13, 2000.
  • The Fonar 52-week high stock price is 26.49, which is 21.5% above the current share price.
  • The Fonar 52-week low stock price is 11.00, which is 49.6% below the current share price.
  • The average Fonar stock price for the last 52 weeks is 20.77.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Fonar Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 21.0228 20.1900 26.4900 11.2100 21.8100 10.77%
2019 21.2884 21.2500 25.0700 19.2000 19.6900 -2.72%
2018 25.3970 24.3500 29.8000 20.0700 20.2400 -16.88%
2017 24.4442 19.2250 33.6000 17.4500 24.3500 27.15%
2016 18.1649 16.7800 23.7800 13.3200 19.1500 10.95%
2015 12.5383 10.2600 18.3300 9.1300 17.2600 65.96%
2014 14.4647 20.1700 26.3200 9.6700 10.4000 -50.96%
2013 8.0377 4.6000 21.2080 4.5900 21.2080 389.79%
2012 3.6961 1.7300 6.4000 1.6900 4.3300 154.11%
2011 1.8012 1.3000 2.6500 1.2600 1.7040 31.08%
2010 1.4940 1.7000 2.7200 1.0200 1.3000 -17.20%
2009 1.6153 0.9200 3.1900 0.6305 1.5700 89.16%
2008 2.4096 5.3200 5.3200 0.6651 0.8300 -84.04%
2007 6.4569 7.5000 8.1400 4.2080 5.2000 -25.71%
2006 12.2490 17.7500 20.5000 6.2500 7.0000 -58.82%
2005 29.9603 39.2500 43.0000 17.0000 17.0000 -56.69%
2004 32.0387 29.0000 42.7500 25.5000 39.2500 36.52%
2003 30.8125 26.7500 49.5000 20.2500 28.7500 7.48%
2002 30.6647 30.5000 50.2500 24.2500 26.7500 -10.08%
2001 37.9819 32.7500 62.2500 25.7500 29.7500 -9.16%
2000 57.9931 46.7500 112.5000 28.0000 32.7500 -22.49%
1999 31.3115 35.2500 75.0000 18.7500 42.2500 35.20%
1998 51.5347 70.2500 75.7500 26.5000 31.2500 -57.48%
1997 71.3014 56.2500 99.2500 54.0000 73.5000 25.64%
1996 61.5492 66.5000 75.7500 53.0000 58.5000 -12.03%
1995 68.0397 47.7500 100.0000 41.5000 66.5000 33.00%
1994 43.3462 54.0000 64.0000 31.2500 50.0000 -7.41%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.142B $0.087B
FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $178.682B 33.53
Medtronic (MDT) Ireland $136.129B 25.64
Stryker (SYK) United States $74.576B 28.92
Boston Scientific (BSX) United States $53.107B 30.68
Lonza Group Ag (LZAGY) Switzerland $45.620B 0.00
Baxter (BAX) United States $39.840B 24.37
Terumo (TRUMY) Japan $30.003B 38.35
Zimmer Biomet Holdings (ZBH) United States $27.355B 22.70
EssilorLuxottica Societe Anonyme (ESLOY) France $27.164B 0.00
ResMed (RMD) United States $24.364B 35.32
Sunny Optical Technology (SNPTF) China $17.659B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.383B 0.00
Bio-Rad Laboratories (BIO) United States $14.666B 66.33
Insulet (PODD) United States $14.217B 601.53
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $8.053B 42.66
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.140B 10.54
Hill-Rom Holdings (HRC) United States $5.406B 13.42
Canopy Growth (CGC) Canada $5.305B 0.00
Haemonetics (HAE) United States $4.393B 29.27
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.250B 0.00
Neogen (NEOG) United States $3.902B 63.97
ICU Medical (ICUI) United States $3.841B 29.31
Envista Holdings (NVST) United States $3.701B 25.24
Abcam (ABCZY) $3.220B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.058B 0.00
TG Therapeutics (TGTX) United States $3.007B 0.00
National Vision Holdings (EYE) United States $2.947B 458.00
NuVasive (NUVA) United States $2.507B 34.94
Agios Pharmaceuticals (AGIO) United States $2.341B 0.00
AtriCure (ATRC) United States $1.724B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.632B 148.92
NanoString Technologies (NSTG) United States $1.620B 0.00
Cardiovascular Systems (CSII) United States $1.415B 0.00
MacroGenics (MGNX) United States $1.336B 0.00
Owens & Minor (OMI) United States $1.295B 29.01
Aphria (APHA) Canada $1.218B 0.00
InMode (INMD) Israel $1.125B 28.37
Cerus (CERS) United States $0.980B 0.00
Quanterix (QTRX) United States $0.898B 0.00
PetIQ (PETQ) United States $0.882B 25.30
BioLife Solutions (BLFS) United States $0.835B 435.00
Lantheus Holdings (LNTH) United States $0.804B 11.14
OraSure Technologies (OSUR) United States $0.762B 0.00
Phibro Animal Health (PAHC) United States $0.713B 16.32
LeMaitre Vascular (LMAT) United States $0.685B 41.80
Meridian Bioscience (VIVO) United States $0.665B 15.36
Vapotherm (VAPO) United States $0.650B 0.00
Aurora Cannabis (ACB) Canada $0.600B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.560B 79.08
Zynex (ZYXI) United States $0.553B 48.27
Omeros (OMER) United States $0.536B 0.00
Surmodics (SRDX) United States $0.517B 56.72
VAREX IMAGING (VREX) United States $0.460B 19.93
Cytosorbents (CTSO) United States $0.327B 0.00
Viemed Healthcare (VMD) United States $0.325B 11.61
HEXO (HEXO) $0.312B 0.00
Utah Medical Products (UTMD) United States $0.285B 24.44
InfuSystems Holdings (INFU) United States $0.265B 50.42
Neptune Wellness Solutions (NEPT) Canada $0.242B 0.00
Surface Oncology (SURF) United States $0.240B 0.00
Organigram Holdings (OGI) Canada $0.210B 0.00
Female Health (VERU) United States $0.184B 0.00
Chimerix (CMRX) United States $0.164B 0.00
Bovie Medical (APYX) United States $0.154B 0.00
Wound Management Technologies (SMTI) United States $0.152B 0.00
Exagen (XGN) United States $0.137B 0.00
Liberty Health Sciences (LHSIF) United States $0.128B 0.00
Evolus (EOLS) United States $0.122B 0.00
Capricor Therapeutics (CAPR) United States $0.098B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.085B 0.00
Chembio Diagnostics (CEMI) United States $0.084B 0.00
Rockwell Medical (RMTI) United States $0.077B 0.00
United-Guardian (UG) United States $0.069B 15.39
Oramed Pharmaceuticals (ORMP) United States $0.065B 0.00
Brainsway (BWAY) Israel $0.061B 0.00
MTech Acquisition (KERN) United States $0.051B 0.00
Nephros (NEPH) United States $0.050B 0.00
Trinity Biotech (TRIB) Ireland $0.048B 9.00
ImmuCell (ICCC) United States $0.039B 0.00
FSD PHARMA INC (HUGE) Canada $0.034B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.018B 0.00
Akers Biosciences Inc (AKER) United States $0.018B 0.00
Myomo (MYO) United States $0.016B 0.00
NF Energy Saving (BIMI) China $0.016B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00